The Arab Drug Company reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported revenue was EGP 222.66 million compared to EGP 171.02 million a year ago. Net income was EGP 38.27 million compared to EGP 25.5 million a year ago. Basic earnings per share from continuing operations was EGP 5.47 compared to EGP 3.78 a year ago.
For the six months, revenue was EGP 413.9 million compared to EGP 324.96 million a year ago. Net income was EGP 65.68 million compared to EGP 53.2 million a year ago. Basic earnings per share from continuing operations was EGP 9.39 compared to EGP 7.76 a year ago.